1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 18,600 | 19,600 | 23:00 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17:09 | Getinge and SteriPro International Inc. announce strategic partnership for sterile processing optimization | 1 | Cision News | ||
| Do | Getinge introduces new version of Solsus 66 to meet CSSD efficiency needs | 3 | Cision News | ||
| 13.11. | GETINGE: Utility-efficient washer-disinfector Aquadis 44 helps hospitals reduce costs and meet environmental targets | 1 | Cision News | ||
| GETINGE AB ADR Aktie jetzt für 0€ handeln | |||||
| 04.11. | Getinge boosts cleanroom efficiency with modern interface for cGMP washers and sterilizers | 2 | Cision News | ||
| 21.10. | Getinge Q3 Profit Surges; Confirms Annual Outlook | 347 | AFX News | STOCKHOLM (dpa-AFX) - Getinge AB (GETI-B.ST), a medtech company, on Tuesday reported a profit before tax of SEK 789 million for the third quarter, a sharp increase from SEK 32 million in the... ► Artikel lesen | |
| 21.10. | Getinge-Aktie steigt nach übertroffenen Quartalsergebnissen | 18 | Investing.com Deutsch | ||
| 21.10. | Getinge AB Non-GAAP EPS of SEK 2.42, revenue of SEK 8.23B; reaffirms FY outlook | 7 | Seeking Alpha | ||
| 21.10. | Getinge AB: Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds | 133 | GlobeNewswire (Europe) | Press release
Gothenburg, Sweden on October 21, 2025
"We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs... ► Artikel lesen | |
| 13.10. | Getinge's Advanta V12 receives CE Mark for major bridging indications | 2 | Cision News | ||
| 07.10. | Getinge invites fund managers, analysts, and media to Q3 Report 2025 conference call | 5 | Cision News | ||
| 02.10. | Philips, Getinge partner on anesthesia monitoring | 2 | MassDevice | ||
| 02.10. | Getinge and Philips introduce integrated anesthesia workstation | 2 | Cision News | ||
| 04.08. | Getinge earns reinstated CE mark for intra-aortic balloon pump | 2 | MassDevice | ||
| 04.08. | GETINGE: EU CE-Mark Reinstated for Cardiosave Intra-Aortic Balloon Pump | 1 | Cision News | ||
| 04.08. | Getinge AB: EU CE-Mark Reinstated for Cardiosave Intra-Aortic Balloon Pump | 213 | GlobeNewswire (Europe) | Press release
Gothenburg, Sweden, on August 4, 2025
Today, Getinge announces that the EU Notified Body TÜV SÜD has reinstated the EU CE Mark for Getinge's Cardiosave Intra-Aortic Balloon Pump (through... ► Artikel lesen | |
| 22.07. | Getinge's Maquet updates instructions for certain neonatal ventilators | 2 | MassDevice | ||
| 18.07. | Getinge Posts Robust Q2 With Organic Growth And Margin Gains, Stock Up | 2 | RTTNews | ||
| 18.07. | Getinge AB (publ) reports Q2 results | 6 | Seeking Alpha | ||
| 18.07. | Getinge Interim Report April-June 2025: Continuing positive trend with stable organic sales growth in all business areas and regions | 235 | PR Newswire | GOTHENBURG, Sweden, July 18, 2025 /PRNewswire/ -- "The positive start to 2025 continued in the second quarter, with stable organic growth in order intake and... ► Artikel lesen | |
| 14.07. | Getinge's iCast covered stent system now available as bridging stent in the U.S. | 1 | Cision News |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 41,670 | +0,65 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 51 auf 48 Euro gesenkt und die Einstufung auf "Equal Weight" belassen. Die Aktienkurse der europäischen... ► Artikel lesen | |
| ESSILORLUXOTTICA | 308,90 | +0,91 % | BARCLAYS stuft EssilorLuxottica auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für EssilorLuxottica von 345 auf 365 Euro angehoben und die Einstufung auf "Overweight" belassen. Die Aktienkurse der... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 128,90 | +3,37 % | Align Technology Stock: Analyst Estimates & Ratings | ||
| INMODE | 12,150 | +1,25 % | InMode Ltd.: InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins | YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| ELEVANCE HEALTH | 292,00 | +2,06 % | Mitsubishi Motors Debuts Mitsubishi Elevance Concept and Adventure-Inspiring Lineup at Japan Mobility Show 2025 | TOKYO, Oct 29, 2025 - (JCN Newswire) - Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) today unveiled the Mitsubishi Elevance Concept, an electrified crossover SUV concept, at the Japan... ► Artikel lesen | |
| TENET | 185,00 | -1,07 % | Tenet Healthcare refinanziert Schulden mit neuer Anleihe über 2,25 Mrd. USD | ||
| BONESUPPORT | 17,740 | +1,95 % | Bonesupport Holding AB: Bonesupport Holding AB (publ) - Publishes Q3 2025 Interim Report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the third quarter 2025.
"Solid growth and new clinical... ► Artikel lesen | |
| ARJO | 2,838 | -0,63 % | Arjo AB: Arjo's interim report January-September 2025 | "Demand remains healthy and we are growing in most markets, which accelerates our growth rate compared with earlier this year. Underlying profitability continued to develop positively, and excluding... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 14,100 | +2,17 % | AMN Healthcare Services Inc: AMN Healthcare Announces Third Quarter 2025 Results | Quarterly revenue of $634 million and adjusted EBITDA of $58 million; GAAP income of $0.76/share and adjusted EPS of $0.39 DALLAS, Nov. 06, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:... ► Artikel lesen | |
| OSSDSIGN | 0,953 | +1,06 % | OssDsign AB: OssDsign AB (publ) publishes Q3 2025 interim report | Record breaking sales month and best quarterly EBIT result
OssDsign AB (publ) announces that the interim report for Q3 2025 is now available as a PDF on the company's website www.ossdsign.com/reports.... ► Artikel lesen | |
| CHECK-CAP | 1,280 | +1,59 % | Check-Cap Ltd. (Operating as MBODY AI): MBody AI ($CHEK) Secures 98% Shareholder Approval to Become Leading Nasdaq Embodied AI Company | Las Vegas, Nevada and Isfiya, Isreal--(Newsfile Corp. - November 17, 2025) - MBody AI Corp. ("MBody AI") and Check-Cap Ltd. (NASDAQ: CHEK) ($CHEK) ("Check-Cap") today announced that Check-Cap shareholders... ► Artikel lesen | |
| FISHER & PAYKEL HEALTHCARE | 17,500 | -4,89 % | Fisher & Paykel Healthcare Profits Surge | ||
| ALPHATEC | 18,650 | +4,13 % | Morning Market Movers: SPS Commerce, Brighthouse Financial, Alphatec, Ardelyx See Big Swings | SEATTLE (dpa-AFX) - At 7:45 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| CROSS COUNTRY HEALTHCARE | 9,850 | +4,23 % | Cross Country Healthcare stock falls as Aya deal faces uncertainty | ||
| STEREOTAXIS | 2,000 | -2,91 % | Stereotaxis, Inc.: Stereotaxis Reports 2025 Third Quarter Financial Results | ST. LOUIS, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results... ► Artikel lesen |
GETINGE AB ADR gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 18,700 Euro und damit +1,08 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GETINGE AB ADR finden Sie auf Wallstreet Online.